Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance

Journal of Infection

Volumn 74, Issue 2, 2017, Pages 142-152

  Fernández Barat, Laia ^b,d   Ferrer, Miquel ^a,b,d   De Rosa, Francesca ^b,c   Gabarrús, Albert ^b,d   Esperatti, Mariano ^b   Terraneo, Silvia ^b,c   Rinaudo, Mariano ^a,b,d   Li Bassi, Gianluigi ^a,b,d   Torres, Antoni ^a,b,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

ICU acquired pneumonia; Inflammatory response; Multidrug resistant pathogens; Pseudomonas aeruginosa; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; ANTIINFECTIVE AGENT;

AGED; ALCOHOL ABUSE; ARTICLE; BACTERIAL COLONIZATION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PLEURA EFFUSION; PRACTICE GUIDELINE; PROPENSITY SCORE; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SHOCK; SOLID TUMOR; SURVIVAL RATE; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA; COMPLICATION; CROSS INFECTION; DRUG EFFECTS; HOSPITAL MORTALITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER DISEASES; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROSPECTIVE STUDY; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LIVER DISEASES; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 85007317291     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.11.008     Document Type: Article

References (47)

1. 1 American Thoracic Society, Infectious Diseases Society of America, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005), 388–416.
2. 2 Esperatti, M., Ferrer, M., Theessen, A., Liapikou, A., Valencia, M., Saucedo, L.M., et al. Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not. Am J Respir Crit Care Med 182 (2010), 1533–1539.
3. 3 European Centre for Disease Prevention and Control, Annual epidemiological report., 2014 1-4-2015. Ref Type: Report.
4. 4 Rosenthal, V.D., Bijie, H., Maki, D.G., Mehta, Y., Apisarnthanarak, A., Medeiros, E.A., et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009. Am J Infect Control 40 (2012), 396–407.
5. 5 Micek, S.T., Wunderink, R.G., Kollef, M.H., Chen, C., Rello, J., Chastre, J., et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care, 19, 2015, 219.
6. 6 Tumbarello, M., De Pascale, G., Trecarichi, E.M., Spanu, T., Antonicelli, F., Maviglia, R., et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 39 (2013), 682–692.
7. 7 Alvarez-Lerma, F., Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-acquired Pneumonia Study Group. Intensive Care Med 22 (1996), 387–394.
8. 8 Kollef, M.H., Chastre, J., Fagon, J.Y., Francois, B., Niederman, M.S., Rello, J., et al. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med 42 (2014), 2178–2187.
9. 9 Fabregas, N., Ewig, S., Torres, A., El Ebiary, M., Ramirez, J., de la Bellacasa, J.P., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54 (1999), 867–873.
10. 10 Woodhead, M.A., Torres, A., Definition and classification of community-acquired and nosocomial pneumonias. Torres, A., Woodhead, M., (eds.) Pneumonia, 1997, European Respiratory Society Journals Ltd., Sheffield, UK, 1–12.
11. 11 Giunta, V., Ferrer, M., Esperatti, M., Ranzani, O.T., Saucedo, L.M., Bassi, G.L., et al. ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med 41 (2013), 2133–2143.
12. 12 Di Pasquale, M., Ferrer, M., Esperatti, M., Crisafulli, E., Giunta, V., Bassi, G.L., et al. Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med 42 (2014), 303–312.
13. 13 Murray, P.R., Baron, E.J.O., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Manual of clinical microbiology. 6th ed., 1995, American Society for Microbiology, Washington, DC.
14. 14 Ferrer, M., Difrancesco, L.F., Liapikou, A., Rinaudo, M., Carbonara, M., Li, B.G., et al. Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome. Crit Care, 19, 2015, 450.
15. 15 Heyland, D.K., Dodek, P., Muscedere, J., Day, A., Cook, D., Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 36 (2008), 737–744.
16. 16 Martin-Loeches, I., Torres, A., Rinaudo, M., Terraneo, S., De, R.F., Ramirez, P., et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect 70 (2015), 213–222.
17. 17 Ioanas, M., Ferrer, M., Cavalcanti, M., Ferrer, R., Ewig, S., Filella, X., et al. Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med 32 (2004), 938–945.
18. 18 Esperatti, M., Ferrer, M., Giunta, V., Ranzani, O.T., Saucedo, L.M., Li, B.G., et al. Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU*. Crit Care Med 41 (2013), 2151–2161.
19. 19 Le Gall, J.R., Lemeshow, S., Saulnier, F., A new simplified acute physiology score (SAPS II) based on a European/North American Multicenter Study. JAMA 270 (1993), 2957–2963.
20. 20 Luna, C.M., Blanzaco, D., Niederman, M.S., Matarucco, W., Baredes, N.C., Desmery, P., et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31 (2003), 676–682.
21. 21 Vincent, J.L., Moreno, R., Takala, J., Willatts, S., De Mendonca, A., Bruining, H., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (1996), 707–710.
22. 22 Dellinger, R.P., Levy, M.M., Carlet, J.M., Bion, J., Parker, M.M., Jaeschke, R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008), 296–327.
23. 23 Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., Fan, E., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 307 (2012), 2526–2533.
24. 24 Ramirez, P., Ferrer, M., Marti, V., Reyes, S., Martinez, R., Menendez, R., et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med 39 (2011), 2211–2217.
25. 25 Bello, S., Lasierra, A.B., Minchole, E., Fandos, S., Ruiz, M.A., Vera, E., et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 39 (2012), 1144–1155.
26. 26 Hosmer, D., Lemeshow, S., Applied logistic regression. 1989, Wiley, New York.
27. 27 Rello, J., Ausina, V., Ricart, M., Castella, J., Prats, G., Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 104 (1993), 1230–1235.
28. 28 Sandiumenge, A., Lisboa, T., Gomez, F., Hernandez, P., Canadell, L., Rello, J., Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms. Chest 140 (2011), 643–651.
29. 29 Chung, D.R., Song, J.H., Kim, S.H., Thamlikitkul, V., Huang, S.G., Wang, H., et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 184 (2011), 1409–1417.
30. 30 Parker, C.M., Kutsogiannis, J., Muscedere, J., Cook, D., Dodek, P., Day, A.G., et al. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 23 (2008), 18–26.
31. 31 Brusselaers, N., Labeau, S., Vogelaers, D., Blot, S., Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 39 (2013), 365–375.
32. 32 Lopez-Ferraz, C., Ramirez, P., Gordon, M., Marti, V., Gil-Perotin, S., Gonzalez, E., et al. Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia. J Infect 69 (2014), 333–340.
33. 33 Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:Suppl. 2 (2007), S27–S72.
34. 34 Trouillet, J.L., Vuagnat, A., Combes, A., Kassis, N., Chastre, J., Gibert, C., Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34 (2002), 1047–1054.
35. 35 El Amari, E.B., Chamot, E., Auckenthaler, R., Pechere, J.C., Van, D.C., Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 33 (2001), 1859–1864.
36. 36 Jong, G.M., Hsiue, T.R., Chen, C.R., Chang, H.Y., Chen, C.W., Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 107 (1995), 214–217.
37. 37 Perlino, C.A., Rimland, D., Alcoholism, leukopenia, and pneumococcal sepsis. Am Rev Respir Dis 132 (1985), 757–760.
38. 38 Palazzo, S.J., Simpson, T., Schnapp, L., Biomarkers for ventilator-associated pneumonia: review of the literature. Heart Lung 40 (2011), 293–298.
39. 39 Micek, S.T., Kollef, M.H., Torres, A., Chen, C., Rello, J., Chastre, J., et al. Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification. Infect Control Hosp Epidemiol 36 (2015), 1190–1197.
40. 40 Makris, D., Desrousseaux, B., Zakynthinos, E., Durocher, A., Nseir, S., The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia. Respir Med 105 (2011), 1022–1029.
41. 41 Rinaudo, M., Ferrer, M., Terraneo, S., De, R.F., Peralta, R., Fernandez-Barat, L., et al. Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia with and without previous intubation. Chest 147 (2015), 1530–1538.
42. 42 Cilloniz, C., Gabarrus, A., Ferrer, M., Puig de la, B.J., Rinaudo, M., Mensa, J., et al. Community-acquired pneumonia due to multidrug and non-multidrug resistant Pseudomonas aeruginosa. Chest 150 (2016), 415–425.
43. 43 Martin-Loeches, I., Deja, M., Koulenti, D., Dimopoulos, G., Marsh, B., Torres, A., et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39 (2013), 672–681.
44. 44 Planquette, B., Timsit, J.F., Misset, B.Y., Schwebel, C., Azoulay, E., Adrie, C., et al. Pseudomonas aeruginosa ventilator-associated pneumonia. Predictive factors of treatment failure. Am J Respir Crit Care Med 188 (2013), 69–76.
45. 45 DiGiandomenico, A., Keller, A.E., Gao, C., Rainey, G.J., Warrener, P., Camara, M.M., et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Sci Transl Med, 6, 2014, 262ra155.
46. 46 Srinivas, N., Jetter, P., Ueberbacher, B.J., Werneburg, M., Zerbe, K., Steinmann, J., et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327 (2010), 1010–1013.
47. 47 Koulenti, D., Lisboa, T., Brun-Buisson, C., Krueger, W., Macor, A., Sole-Violan, J., et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 37 (2009), 2360–2368.